Dupilumab, matched placebo for test product, Ventolin Evohaler 100 micrograms
LPS18583
Approved small_molecule active
Quick answer
Dupilumab, matched placebo for test product, Ventolin Evohaler 100 micrograms for Respiratory tract diseases is a Approved program (small_molecule) at Sanofi Pharma Bristol-Myers Squibb with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Sanofi Pharma Bristol-Myers Squibb
- Indication
- Respiratory tract diseases
- Phase
- Approved
- Modality
- small_molecule
- Status
- active